HX009, a novel BsAb dual targeting PD1 x CD47, demonstrates potent anti-lymphoma activity in preclinical models
HX009 是一种新型 BsAb 双靶向 PD1 x CD47,在临床前模型中表现出强大的抗淋巴瘤活性
期刊:Scientific Reports
影响因子:3.8
doi:10.1038/s41598-023-32547-y
Hang Ke, Faming Zhang, Jingjing Wang, Lingxin Xiong, Xiaoyu An, Xiaolong Tu, Cen Chen, Yueying Wang, Binchen Mao, Sheng Guo, Cunxiang Ju, Xiangfei He, Ruilin Sun, Lei Zhang, Owen A O'Connor, Qi-Xiang Li